• Je něco špatně v tomto záznamu ?

Rearrangement of KMT2A Characterizes a Subset of Pediatric Parotid Mucoepidermoid Carcinomas Arising Metachronous to Acute Lymphoblastic Leukemia

BK. Othman, P. Steiner, I. Leivo, A. Skálová

. 2023 ; 42 (5) : 796-807. [pub] 20230730

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016114

Introduction: Metachronous mucoepidermoid carcinomas (MMEC) may occur in association with childhood leukemias and lymphomas. We compared molecular abnormalities of MMEC in patients with ALL with the abnormalities found in primary mucoepidermoid carcinomas (MECs) in pediatric cases and young adults. Materials and methods: Immunohistochemical stains for p63 and SOX10, molecular alterations in MAML2 and KMT2A genes detected by FISH and/or next-generation sequencing were studied in 12 pediatric MMECs secondary to ALL and six primary MECs in pediatric patients and young adults. Follow-up information of patients in both groups was obtained. Results:KMT2A rearrangements were detected in pediatric MMECs, and they were associated with remarkable histomorphological changes, including deposits of abundant stromal collagen and intratumoral lymphoid proliferations. No KMT2A rearrangements were found in primary MECs. The prognosis of MMEC in patients with ALL, especially in KMT2A-rearranged cases, was worse than in primary MECs. Kruskal-Wallis test showed a statistically significant difference in overall survival between KMT2A-rearranged MMECs and KMT2A-intact MMECs in cases with ALL (p = 0.027). Conclusion:KMT2A-rearranged MMECs in ALL patients may have inherently more aggressive behavior, even when the histomorphology of MMEC suggests a low-grade malignancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016114
003      
CZ-PrNML
005      
20231026110410.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/15513815.2023.2241903 $2 doi
035    __
$a (PubMed)37517063
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Othman, Bacem K $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic
245    10
$a Rearrangement of KMT2A Characterizes a Subset of Pediatric Parotid Mucoepidermoid Carcinomas Arising Metachronous to Acute Lymphoblastic Leukemia / $c BK. Othman, P. Steiner, I. Leivo, A. Skálová
520    9_
$a Introduction: Metachronous mucoepidermoid carcinomas (MMEC) may occur in association with childhood leukemias and lymphomas. We compared molecular abnormalities of MMEC in patients with ALL with the abnormalities found in primary mucoepidermoid carcinomas (MECs) in pediatric cases and young adults. Materials and methods: Immunohistochemical stains for p63 and SOX10, molecular alterations in MAML2 and KMT2A genes detected by FISH and/or next-generation sequencing were studied in 12 pediatric MMECs secondary to ALL and six primary MECs in pediatric patients and young adults. Follow-up information of patients in both groups was obtained. Results:KMT2A rearrangements were detected in pediatric MMECs, and they were associated with remarkable histomorphological changes, including deposits of abundant stromal collagen and intratumoral lymphoid proliferations. No KMT2A rearrangements were found in primary MECs. The prognosis of MMEC in patients with ALL, especially in KMT2A-rearranged cases, was worse than in primary MECs. Kruskal-Wallis test showed a statistically significant difference in overall survival between KMT2A-rearranged MMECs and KMT2A-intact MMECs in cases with ALL (p = 0.027). Conclusion:KMT2A-rearranged MMECs in ALL patients may have inherently more aggressive behavior, even when the histomorphology of MMEC suggests a low-grade malignancy.
650    _2
$a mladý dospělý $7 D055815
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a DNA vazebné proteiny $x genetika $7 D004268
650    _2
$a trans-aktivátory $x genetika $7 D015534
650    12
$a mukoepidermoidní karcinom $x genetika $x patologie $7 D018277
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    12
$a akutní lymfatická leukemie $7 D054198
650    _2
$a genová přestavba $7 D015321
655    _2
$a časopisecké články $7 D016428
700    1_
$a Steiner, Petr $u Molecular Genetic Laboratory, Bioptic Laboratory, Pilsen, Czech Republic
700    1_
$a Leivo, Ilmo $u Institute of Biomedicine, Pathology, University of Turku, and Turku University Hospital, Turku, Finland
700    1_
$a Skálová, Alena $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic $u Department of Pathology, Bioptic Laboratory, Ltd, Pilsen, Czech Republic
773    0_
$w MED00008535 $t Fetal and pediatric pathology $x 1551-3823 $g Roč. 42, č. 5 (2023), s. 796-807
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37517063 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110403 $b ABA008
999    __
$a ok $b bmc $g 1999935 $s 1202476
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 42 $c 5 $d 796-807 $e 20230730 $i 1551-3823 $m Fetal and pediatric pathology $n Fetal Pediat Pathol $x MED00008535
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace